CHI3L1 and colorectal cancer: Future studies with larger, multicenter, and more diverse cohorts are warranted to confirm these findings, validate the diagnostic utility of YKL-40 and RLN2, and explore their potential integration into multi-marker panels for colorectal cancer detection and monitoring.